5-Hydroxytryptamine uptake inhibitors antagonize the antireserpine effects of noradrenaline uptake inhibitors.
D000818:Animals; D001977:Brompheniramine / Q000031:analogs & derivatives / Q000494:pharmacology; D015283:Citalopram; D016666:Fluvoxamine; D008297:Male; D051379:Mice; D009043:Motor Activity / Q000187:drug effects; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000378:metabolism*; D010091:Oximes / Q000494:pharmacology; D011437:Propylamines / Q000494:pharmacology; D012110:Reserpine / Q000037:antagonists & inhibitors*; D012702:Serotonin Antagonists / Q000494:pharmacology*; D013747:Tetrabenazine / Q000494:pharmacology; D015031:Zimeldine
D010091:Oximes; D011437:Propylamines; D012702:Serotonin Antagonists; D015283:Citalopram; D015031:Zimeldine; D012110:Reserpine; D001977:Brompheniramine; D016666:Fluvoxamine; D009638:Norepinephrine; D013747:Tetrabenazine